相关产品推荐更多 >

HLA-A2, A28 Antibody, anti-human, FITC, REAfinity™, 100 tests in 200 µL
询价
CD314 (NKG2D) Antibody, anti-human, Vio® Bright FITC, 30 tests in 60 µL
询价
CD97 Antibody, anti-human, APC-Vio® 770, 30 tests in 300 µL
询价
DAP12 Antibody, anti-human, APC, REAfinity™, 30 tests in 60 µL
询价
CD307a (FcRL1) Antibody, anti-mouse, PE, REAfinity™, 30 µg in 1 mL
询价
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
HLA Class I Bw4
- 亚型:
recombinant human IgG1
- 形态:
Reagents are supplied in buffer containing stabilizer and 0.05% sodium azide.
- 保存条件:
避光,2-8℃
- 克隆性:
REA274
- 标记物:
Biotin
- 适应物种:
human
- 保质期:
24个月
- 供应商:
Miltenyi Biotec
- 宿主:
human cell line
- 应用范围:
Flow cytometry
- 浓度:
1:50
- 抗体英文名:
HLA Class I Bw4 Antibody, anti-human, REAfinity™
- 抗体名:
HLA Class I Bw4 Antibody, anti-human, REAfinity™
- 规格:
100 tests in 200 µL
Identification and enumeration of HLA class I Bw4+ cells by flow cytometryClone REA274 recognizes HLA Bw4, a class I human leukocyte antigen (HLA). Expressed on the surface of most nucleated cells, class I molecules are heterodimeric molecules and consist of a type I integral membrane α heavy chain and soluble β2 microglobulin protein. The extracellular region of the heavy chain further consists of three domains, one of which comprises the peptide binding groove. Antigens binding to class I molecules are 8–10 amino acids long and play an important role in recognition of the virus infected and malignant cells by cytotoxic T lymphocytes (CTLs). In addition, class I molecules interact with NK cell receptors to modulate the activity of NK cells. Analysis of HIV-infected patients found the combination of the NK cell receptor KIR3DS1/L1 and a presumptive HLA Bw4 ligand to be correlated with slower progression to AIDS. | Additional information: Clone REA274 displays negligible binding to Fc receptors. |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验该产品被引用文献
Carr, W. H. et al. (2005) KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J Immunol 175 (8): 5222–5229. | Hewitt, E. W. et al. (2003) The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110 (2): 163–169. | Martin, M. P. et al. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39 (6): 733–740. | Garrido, C. et al. (2016) HIV latency-reversing agents have diverse effects on natural killer cell function. Front Immunol 7: 356.
技术资料暂无技术资料 索取技术资料
文献支持
HLA Class I Bw4 Antibody, anti-human, Biotin, REAfinity™, 100 tests in 200 µL
询价





